Skin cancer drug approved by UK regulators
Roche’s skin cancer drug, Erivedge (vismodegib), has been approved by regulators to treat people with severe basal cell carcinoma (BCC).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Pharmaceuticals | Skin | Skin Cancer